Your browser doesn't support javascript.
loading
Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris.
Giribaldi, Julien; Ragnarsson, Lotten; Pujante, Tom; Enjalbal, Christine; Wilson, David; Daly, Norelle L; Lewis, Richard J; Dutertre, Sebastien.
Afiliação
  • Giribaldi J; Institut des Biomolécules Max Mousseron, UMR 5247, Université de Montpellier-CNRS, 34095 Montpellier, France.
  • Ragnarsson L; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Pujante T; Institut des Biomolécules Max Mousseron, UMR 5247, Université de Montpellier-CNRS, 34095 Montpellier, France.
  • Enjalbal C; Institut des Biomolécules Max Mousseron, UMR 5247, Université de Montpellier-CNRS, 34095 Montpellier, France.
  • Wilson D; Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD 4878, Australia.
  • Daly NL; Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD 4878, Australia.
  • Lewis RJ; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Dutertre S; Institut des Biomolécules Max Mousseron, UMR 5247, Université de Montpellier-CNRS, 34095 Montpellier, France.
Mar Drugs ; 18(3)2020 Mar 06.
Article em En | MEDLINE | ID: mdl-32155768
ABSTRACT
Cone snails produce a fast-acting and often paralyzing venom, largely dominated by disulfide-rich conotoxins targeting ion channels. Although disulfide-poor conopeptides are usually minor components of cone snail venoms, their ability to target key membrane receptors such as GPCRs make them highly valuable as drug lead compounds. From the venom gland transcriptome of Conus miliaris, we report here on the discovery and characterization of two conopressins, which are nonapeptide ligands of the vasopressin/oxytocin receptor family. These novel sequence variants show unusual features, including a charge inversion at the critical position 8, with an aspartate instead of a highly conserved lysine or arginine residue. Both the amidated and acid C-terminal analogues were synthesized, followed by pharmacological characterization on human and zebrafish receptors and structural investigation by NMR. Whereas conopressin-M1 showed weak and only partial agonist activity at hV1bR (amidated form only) and ZFV1a1R (both amidated and acid form), both conopressin-M2 analogues acted as full agonists at the ZFV2 receptor with low micromolar affinity. Together with the NMR structures of amidated conopressins-M1, -M2 and -G, this study provides novel structure-activity relationship information that may help in the design of more selective ligands.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Conotoxinas / Caramujo Conus Limite: Animals / Humans Idioma: En Revista: Mar Drugs Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Conotoxinas / Caramujo Conus Limite: Animals / Humans Idioma: En Revista: Mar Drugs Ano de publicação: 2020 Tipo de documento: Article